EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Smart R&D Pathways and Export Competitiveness: A Comparative Analysis of Bangladesh and China's Pharmaceutical Industry

Deepto Chakraborty, Nirjona Mondal

Research Journal in Business and Economics · 20.07.2026 · 4 (3) · 32-48

DOI: 10.61424/rjbe.v4i3.955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research Journal in Business and Economics, online erschienen am 20.07.2026. Verfasst von Deepto Chakraborty und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines how smart research and development (R&D) financing can promote sustainable pharmaceutical export growth by comparing Bangladesh and China. Using descriptive statistical analysis and secondary data from 2020–2025, the study evaluates pharmaceutical exports, R&D expenditure, domestic credit to the private sector, and GDP growth. The findings show that China's strong performance is supported by sustained R&D investment, diversified financing mechanisms, and coordinated government policies that foster innovation and high-value pharmaceutical exports. In contrast, Bangladesh has achieved notable success in generic medicine production and export expansion but continues to face challenges, including low R&D investment, limited innovation financing, and weak industry–university collaboration. As Bangladesh prepares for post-LDC graduation, strengthening its innovation ecosystem through increased R&D funding, financial incentives, venture capital, and institutional reforms will be crucial for maintaining export competitiveness. The study concludes that adopting smart R&D financing strategies can help Bangladesh transition toward an innovation-driven pharmaceutical industry and achieve sustainable export growth.

Zitieren

APA

Chakraborty, D., & Mondal, N. (2026). Smart R&D Pathways and Export Competitiveness: A Comparative Analysis of Bangladesh and China's Pharmaceutical Industry. Research Journal in Business and Economics, 4(3), 32-48. https://doi.org/10.61424/rjbe.v4i3.955

Vancouver

Chakraborty D, Mondal N. Smart R&D Pathways and Export Competitiveness: A Comparative Analysis of Bangladesh and China's Pharmaceutical Industry. Research Journal in Business and Economics. 2026;4(3):32-48. doi:10.61424/rjbe.v4i3.955

BibTeX
@article{Chakraborty2026,
  author = {Chakraborty, Deepto and Mondal, Nirjona},
  title = {Smart R&D Pathways and Export Competitiveness: A Comparative Analysis of Bangladesh and China's Pharmaceutical Industry},
  journal = {Research Journal in Business and Economics},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {32--48},
  doi = {10.61424/rjbe.v4i3.955}
}
Kostenlos starten →